10 firms writing Biotech checks in San Diego, led by Abingworth, Logos Capital, SR One — ranked by verified deal count with the companies behind each.
Biotech in San Diego accounts for 24 tracked companies with verified cap-table data, 24 of which disclose round sizes totalling $4.1B. The median disclosed raise is $120M, and the largest is Mirador Therapeutics at $650M, ahead of Avenzo Therapeutics ($446M) and Candid Therapeutics ($370M).
The names that recur most often on these biotech cap tables are OrbiMed (5 companies), Versant Ventures (5 companies), Nextech Invest (4 companies), Alexandria Venture Investments (4 companies), ARCH Venture Partners (3 companies), Invus (3 companies). By latest disclosed round, the market skews Series A (13), Series B (9), Series C (1), Seed (1).
Companies tracked: 24
Disclosed funding total: $4.1B across 24 companies
Median disclosed raise: $120M
Largest raise: Mirador Therapeutics — $650M
Stage mix: Series A 13 · Series B 9 · Series C 1 · Seed 1
